Involvement of ITF2 in the Transcriptional Regulation of
Melanogenic Genes*
Minao
Furumura
,
S. Brian
Potterf
,
Kazutomo
Toyofuku
,
Jun
Matsunaga
,
Jacqueline
Muller§, and
Vincent J.
Hearing
¶
From the
Pigment Cell Biology Section, Laboratory of
Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland
20892 and the § Division of Virology, Center for Biologics
Evaluation and Research, Food and Drug Administration, Bethesda,
Maryland 20892
In response to agouti signal protein,
melanocytes switch from producing eumelanin to pheomelanin concomitant
with the down-regulation of melanogenic gene transcription. We
previously reported that a ubiquitous basic helix-loop-helix
transcription factor, known as ITF2, is up-regulated during this
switch, and we now report that treatment of melanocytes with
melanocyte-stimulating hormone down-regulates expression of ITF2. To
more fully characterize the involvement of ITF2 in regulating
melanogenic gene transcription, ITF2 sense or antisense constructs were
introduced into melan-a melanocytes. Gene and protein expression
analyses and luciferase reporter assays using promoters from
melanogenic genes showed that up-regulation of ITF2 suppressed
melanogenic gene expression as well as the expression of Mitf, a
melanocyte-specific transcription factor. In addition, stable ITF2
sense transfectants had significant reductions in pigmentation and a
less dendritic phenotype compared with mock transfectants. In contrast,
ITF2 antisense-transfected melanocytes were more pigmented and more
dendritic. These results demonstrate that up-regulation of ITF2 during
the pheomelanin switch is functionally significant and reveal that
differential expression of a ubiquitous basic helix-loop-helix
transcription factor can modulate expression of melanogenic genes and
the differentiation of melanocytes.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.